⚠ BETA β€” all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026

NSE

GlaxoSmithKline Pharmaceuticals LimitedGLAXO

GLAXOβ‚Ή2,199.8β–² 4.59% today
Nifty Midcap 150

GlaxoSmithKline Pharmaceuticals Limited is a leading pharmaceutical company in India, offering a wide range of prescription and over-the-counter medicines. The company focuses on developing innovative treatments for various diseases.

Key productsAugmentin, Tavizol, Vigilon
GeographyIndia
CompetitorsSun Pharma, Cipla, Dr. Reddy's Laboratories

AI-generated overview β€” verify before relying on it.

Net institutional flow

No institutional deals

Institutional buyers

0 in / 0 out

High-impact filings

0 Β· tilt Neutral

Next corporate action

Dividend - Rs 57 Per Share

ex 2026-05-29

Competitive landscape β€” the read

vs mapped peers Β· 1Y
Institutional money is backing ACC hardest (+β‚Ή187.8 Cr net). GLAXO ranks #2 of 9 on flow (net buying +β‚Ή0 Cr). News & social buzz is most positive on AIAENG.
#CompanyInst. flow β‚ΉCrDealsHi-impactFiling mom.BuzzNews
1ACC+β‚Ή187.8 Cr1β€”β€”β€”β€”
2GLAXOThisβ€”β€”β€”β€”β€”β€”
33MINDIAβ€”β€”β€”β€”β€”β€”
4AIAENGβ€”β€”β€”β€”+1320
5APLAPOLLO+β‚Ή0 Cr2β€”β€”β€”β€”
6AUBANK+β‚Ή0 Cr4β€”β€”β€”β€”
7AWL+β‚Ή0 Cr2β€”β€”β€”β€”
8ABBOTINDIAβ€”β€”β€”β€”+217
9360ONEβˆ’β‚Ή870.1 Cr9β€”β€”+922

Ranked by net institutional flow (buys βˆ’ sells, β‚ΉCr). Filing momentum = bullish βˆ’ bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline β€” GLAXO day by day

Merged from deals, filings, corporate actions and news β€” newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

Bulk & block deals

No bulk/block deals for GLAXO in this window.

News & chatter on GLAXO

RSS News

0

No recent news.

Google News RSS β€” links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.